Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Investigating the role and prognostic utility of white matter hyperintensities in Amyotrophic Lateral Sclerosis
FY 2024-25
Summary
Amyotrophic Lateral Sclerosis (ALS) is a terminal neurodegenerative disease characterized by progressive loss of motor function and has no cure. While it is known that patients with ALS experience changes in certain brain regions, the relationships between these brain-related changes, patient symptoms, and survival outcomes remain unknown. Combining machine learning with magnetic resonance imaging-based brain measures, we propose to develop models that can track disease progression in patients and predict their future symptoms and survival outcomes using white matter lesions as a biomarker. These lesions, white matter hyperintensities (WMHs), present as increased signal in fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI). Previous work has validated WMHs as a biomarker of disease progression in the context of other diseases, but the use in ALS remains unexplored. This can now be achieved using newly available data that contains MRIs, clinical assessments, and patient demographics. Using longitudinal data from 232 ALS patients and 207 matched controls, I will investigate the applicability of WMHs as a biomarker for disease severity and progression in ALS and develop predictive models for the prognosis of individual ALS patients. The proposed study will lead to the assessment of WMHs as a biomarker of ALS and the development of prognostic models for disease management and clinical trial enrichment. By combining advanced MRI analysis and machine learning techniques, we can uncover complex data patterns that would otherwise remain undetectable. Finally, as WMHs are a marker of cerebrovascular disease, they can be controlled by management of vascular risk factors including hypertension, providing new avenues for preventative strategies in ALS.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
530014
Name
Chadwick Katherine M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role and prognostic utility of white matter hyperintensities in Amyotrophic Lateral Sclerosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Biomarkers; Cognition; Disease Progression; Machine Learning; Mri Imaging; Neurodegenerative Diseases; Prognostic Models; Survival Outcomes; White Matter Hyperintensities
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a terminal neurodegenerative disease characterized by progressive loss of motor function and has no cure. While it is known that patients with ALS experience changes in certain brain regions, the relationships between these brain-related changes, patient symptoms, and survival outcomes remain unknown. Combining machine learning with magnetic resonance imaging-based brain measures, we propose to develop models that can track disease progression in patients and predict their future symptoms and survival outcomes using white matter lesions as a biomarker. These lesions, white matter hyperintensities (WMHs), present as increased signal in fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI). Previous work has validated WMHs as a biomarker of disease progression in the context of other diseases, but the use in ALS remains unexplored. This can now be achieved using newly available data that contains MRIs, clinical assessments, and patient demographics. Using longitudinal data from 232 ALS patients and 207 matched controls, I will investigate the applicability of WMHs as a biomarker for disease severity and progression in ALS and develop predictive models for the prognosis of individual ALS patients. The proposed study will lead to the assessment of WMHs as a biomarker of ALS and the development of prognostic models for disease management and clinical trial enrichment. By combining advanced MRI analysis and machine learning techniques, we can uncover complex data patterns that would otherwise remain undetectable. Finally, as WMHs are a marker of cerebrovascular disease, they can be controlled by management of vascular risk factors including hypertension, providing new avenues for preventative strategies in ALS.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chadwick, Katherine M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~